Suppr超能文献

印度疼痛研究协会癌症疼痛特别兴趣小组癌症疼痛药物治疗指南(第三部分)

Indian Society for Study of Pain, Cancer Pain Special Interest Group Guidelines on Pharmacological Management of Cancer Pain (Part III).

作者信息

Ramanjulu Raghavendra, Thota Raghu S, Ahmed Arif, Jain Parmanand, Bhatnagar Sushma, Salins Naveen, Chatterjee Aparna, Bhattacharya Dipasri

机构信息

Department of Pain and Palliative Care, Cytecare Hospital, Bengaluru, Karnataka, India.

Department of Anaesthesiology, Critical Care and Pain, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.

出版信息

Indian J Palliat Care. 2020 Apr-Jun;26(2):191-197. doi: 10.4103/0973-1075.285694.

Abstract

The Indian Society for Study of Pain (ISSP), Cancer Pain Special Interest Group, guidelines on pharmacological management of cancer pain in adults provide a structured, step-wise approach which will help to improve the management of cancer pain and to provide patients with a minimally acceptable quality of life. The guidelines have been developed based on the available literature and evidence, to suit the needs, patient population, and situations in India. A questionnaire based on the key elements of each sub draft addressing certain inconclusive areas where evidence was lacking, was made available on the ISSP website and circulated by E-mail to all the ISSP and Indian Association of Palliative Care members. Antidepressants and/or anticonvulsants should be used to treat neuropathic cancer pain and the dose should be titrated according to the clinical response and side effects. External beam radiotherapy should be offered to all patients with painful metastatic bone pain. There is evidence on the use of ketamine in cancer neuropathic pain, but with no beneficial effect, thus it is not recommended.

摘要

印度疼痛研究协会(ISSP)癌症疼痛特别兴趣小组发布的成人癌症疼痛药物治疗指南提供了一种结构化的、循序渐进的方法,这将有助于改善癌症疼痛的管理,并为患者提供最低可接受的生活质量。这些指南是根据现有文献和证据制定的,以适应印度的需求、患者群体和情况。基于每个子草案的关键要素制作了一份问卷,用于解决某些缺乏证据的不确定领域,并在ISSP网站上发布,并通过电子邮件分发给所有ISSP成员和印度姑息治疗协会成员。应使用抗抑郁药和/或抗惊厥药治疗神经性癌症疼痛,剂量应根据临床反应和副作用进行滴定。所有有疼痛性转移性骨痛的患者均应接受外照射放疗。有证据表明氯胺酮可用于癌症神经性疼痛,但无有益效果,因此不推荐使用。

相似文献

8

引用本文的文献

本文引用的文献

4
Ketamine as an adjuvant to opioids for cancer pain.氯胺酮作为阿片类药物治疗癌痛的辅助用药。
Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD003351. doi: 10.1002/14651858.CD003351.pub3.
5
WITHDRAWN: Radioisotopes for metastatic bone pain.撤回:用于转移性骨痛的放射性同位素。
Cochrane Database Syst Rev. 2017 Mar 23;3(3):CD003347. doi: 10.1002/14651858.CD003347.pub3.
6
Ketamine for cancer pain: what is the evidence?氯胺酮用于癌症疼痛:证据是什么?
Curr Opin Support Palliat Care. 2017 Jun;11(2):88-92. doi: 10.1097/SPC.0000000000000262.
9
Corticosteroids for the management of cancer-related pain in adults.皮质类固醇用于成人癌症相关疼痛的管理。
Cochrane Database Syst Rev. 2015 Apr 24;2015(4):CD010756. doi: 10.1002/14651858.CD010756.pub2.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验